Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between clonogenic cell growth and clinical risk group in B-cell chronic lymphocytic leukemia.

Blood - 1 Jul 1990

Dadmarz R, Rabinowe S N, Cannistra S A, Andersen J W, Freedman A S, Nadler L M

Abstract excerpt

Chronic lymphocytic leukemia of B-cell origin (B-CLL) is a disease with a variable clinical course, despite the fact that the neoplastic cells in this disorder are homogeneous with respect to morphology, immunophenotype, and cell cycle stage. To further investigate the heterogeneity observed in the clinical behavior of B-CLL, we determined the phenotype and growth requirements of clonogenic cells from 28 patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Factors
Share to Cell Line
Share to Clone Cells

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Culture Media

Share to Cytokines

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Phenotype

Share to Risk Factors

Source

Identifiers

PMID: 2194588

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Association between clonogenic cell growth and clinical risk group in B-cell chronic lymphocytic leukemia.PMID 2194588Read ↗

Immunobiology of chronic lymphocytic leukemia.Semantic proximity Read ↗

Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations.Semantic proximity Read ↗

Exogenous interleukin 2 (IL 2) reconstitutes deficient in vitro T-cell growth of patients with chronic lymphocytic leukemia of B-cell lineage (B-CLL).Semantic proximity Read ↗

Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression.Semantic proximity Read ↗

Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.Semantic proximity Read ↗

TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B CellsSemantic proximity Read ↗

Lack of allelic exclusion in B cell chronic lymphocytic leukemia.Semantic proximity Read ↗

Differentiation commitment and regulator-specific granulocyte-macrophage maturation in a novel pro-B murine leukemic cell line.Semantic proximity Read ↗

Stimulation of growth of human malignant lymphoma and lymphoid leukemia cells in vitro.Semantic proximity Read ↗

In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow.Semantic proximity Read ↗

Significance of phosphotyrosine proteins, Bcl-2 and p53 for apoptosis in resting B-chronic lymphocytic leukemia (CLL) cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.